Jordan Harry’s Conversation on Cancer and Clot Risk with Thrombosis Canada
Jordan Harry, Summer Research Assistant at Providence Care, shared a proud post on LinkedIn:
“Just Released — My Conversation on Cancer and Clot Risk with Thrombosis Canada
I recently had the opportunity to join CLOT Conversations, a podcast by Thrombosis Canada, to talk about our recent research on cancer-associated thrombosis – a serious but often overlooked complication in oncology care.
In the episode, we cover:
-Which solid cancers carry the highest risk of VTE
-How sex and geography influence risk
-What this means for patient care and what needs to change
This work was made possible by an incredible team: Regan Bucciol, Deirdre Finnigan, Hussein Hashem, and Ahmad Alaraki, MBBS. Thank you for your insight and dedication throughout the project.
A special thanks to Dr. Maha Othman MD MSc PhD., whose mentorship and guidance
made this work possible from day one.
Grateful to Thrombosis Canada for the opportunity to share our findings, and to St. Lawrence College and Queen’s University for supporting this work.”
Listen to the episode.
Read the Publication.
Article: The incidence of venous thromboembolism by type of solid cancer worldwide: A systematic review
Authors: Jordan Harry, Regan Bucciol, Deirdre Finnigan, Hussein Hashem, Ahmad Araki, Maha Othman
Stay updated on all science in the field with Hemostasis Today.
-
Aug 13, 2025, 09:21VELORA Discover Study Now Enrolling: Advancing Care for Type 1 Von Willebrand Disease
-
Aug 13, 2025, 06:44Chokri Ben Lamine: Causes and Diagnostic Approach to PTT Prolongation
-
Aug 13, 2025, 05:41ISTH 2025 Recorded Sessions Now Available on ISTH Academy
-
Aug 13, 2025, 01:39Radoslaw Kaczmarek: Challenges Limiting Gene Therapy Use in Hemophilia
-
Aug 12, 2025, 20:03David McIntosh Urges WHO, the European Blood Alliance, the International Plasma and Fractionation Association to Stop Opposition to VRCD
-
Aug 14, 2025, 03:25TNFα Role in Body’s Recovery from Anemia of Inflammation
-
Aug 13, 2025, 23:32Cedric Hermans Shares His Vision for the Use of APCC During Emicizumab Prophylaxis
-
Aug 13, 2025, 16:24Giuseppe Lippi on Laboratory Diagnostics for Immediate Management of Acute Bleeding
-
Aug 13, 2025, 06:13Pip Nicolson: Understanding VITT From COVID-19 Vaccines
-
Aug 13, 2025, 05:23Baseline Hemoglobin Predicts Outcomes in Acute VTE: Low Hb Linked to Higher Bleeding, Ischemia and Mortality Risk
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada
-
Aug 13, 2025, 15:50Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
-
Aug 13, 2025, 10:25Joshua Muia on His HTRS Leadership Role Impact
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot